Bingchen Han

1.3k total citations
16 papers, 767 citations indexed

About

Bingchen Han is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Bingchen Han has authored 16 papers receiving a total of 767 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Oncology and 4 papers in Genetics. Recurrent topics in Bingchen Han's work include Cancer Cells and Metastasis (9 papers), FOXO transcription factor regulation (4 papers) and Pluripotent Stem Cells Research (3 papers). Bingchen Han is often cited by papers focused on Cancer Cells and Metastasis (9 papers), FOXO transcription factor regulation (4 papers) and Pluripotent Stem Cells Research (3 papers). Bingchen Han collaborates with scholars based in United States, China and Singapore. Bingchen Han's co-authors include Xiaojiang Cui, Armando E. Giuliano, Ying Qu, Yukun Cui, Liting Jin, Emily Siegel, Shikha Bose, Beth Y. Karlan, Weiwu Yao and Yi Yu and has published in prestigious journals such as PLoS ONE, JNCI Journal of the National Cancer Institute and Oncogene.

In The Last Decade

Bingchen Han

15 papers receiving 758 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bingchen Han United States 12 434 342 180 114 82 16 767
Silvia Lemma Italy 15 472 1.1× 204 0.6× 222 1.2× 93 0.8× 79 1.0× 20 802
Sanghyun Lee South Korea 5 610 1.4× 439 1.3× 266 1.5× 87 0.8× 92 1.1× 6 923
Nayoung Jun South Korea 4 607 1.4× 440 1.3× 267 1.5× 87 0.8× 92 1.1× 7 919
Haozhe Piao China 18 435 1.0× 179 0.5× 221 1.2× 98 0.9× 101 1.2× 54 791
Carmen Griñán‐Lisón Spain 18 512 1.2× 342 1.0× 318 1.8× 174 1.5× 77 0.9× 39 969
Hanna Dillekås Norway 4 308 0.7× 294 0.9× 221 1.2× 90 0.8× 73 0.9× 6 702
Torsten Kroll Germany 16 301 0.7× 324 0.9× 226 1.3× 88 0.8× 107 1.3× 29 717
Karolina Sterzyńska Poland 18 428 1.0× 325 1.0× 226 1.3× 101 0.9× 67 0.8× 36 811
Shuang Yan China 17 466 1.1× 215 0.6× 135 0.8× 61 0.5× 72 0.9× 50 801
Yeonhwa Song South Korea 16 343 0.8× 297 0.9× 184 1.0× 104 0.9× 60 0.7× 25 699

Countries citing papers authored by Bingchen Han

Since Specialization
Citations

This map shows the geographic impact of Bingchen Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bingchen Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bingchen Han more than expected).

Fields of papers citing papers by Bingchen Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bingchen Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bingchen Han. The network helps show where Bingchen Han may publish in the future.

Co-authorship network of co-authors of Bingchen Han

This figure shows the co-authorship network connecting the top 25 collaborators of Bingchen Han. A scholar is included among the top collaborators of Bingchen Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bingchen Han. Bingchen Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Liu, Qizhi, Stacey Chung, Bingchen Han, et al.. (2022). TOP1 inhibition induces bifurcated JNK/MYC signaling that dictates cancer cell sensitivity. International Journal of Biological Sciences. 18(10). 4203–4218.
2.
Han, Bingchen, Zhe Wang, Nan Deng, et al.. (2021). A chemokine regulatory loop induces cholesterol synthesis in lung-colonizing triple-negative breast cancer cells to fuel metastatic growth. Molecular Therapy. 30(2). 672–687. 19 indexed citations
3.
Gao, Bowen, Bingchen Han, Xinfeng Zhang, et al.. (2021). Identification of triptonide as a therapeutic agent for triple negative breast cancer treatment. Scientific Reports. 11(1). 2408–2408. 8 indexed citations
4.
Xu, Liang, et al.. (2020). Multiple myeloma: Combination therapy of BET proteolysis targeting chimeric molecule with CDK9 inhibitor. PLoS ONE. 15(6). e0232068–e0232068. 15 indexed citations
5.
Jin, Liting, Bingchen Han, Emily Siegel, et al.. (2018). Breast cancer lung metastasis: Molecular biology and therapeutic implications. Cancer Biology & Therapy. 19(10). 858–868. 217 indexed citations
6.
Han, Bingchen, Bo Zhou, Ying Qu, et al.. (2017). FOXC1-induced non-canonical WNT5A-MMP7 signaling regulates invasiveness in triple-negative breast cancer. Oncogene. 37(10). 1399–1408. 62 indexed citations
7.
Qu, Ying, Bingchen Han, Bowen Gao, et al.. (2017). Differentiation of Human Induced Pluripotent Stem Cells to Mammary-like Organoids. Stem Cell Reports. 8(2). 205–215. 55 indexed citations
8.
Gao, Bowen, Ying Qu, Bingchen Han, et al.. (2017). Inhibition of lobuloalveolar development by FOXC1 overexpression in the mouse mammary gland. Scientific Reports. 7(1). 14017–14017. 6 indexed citations
9.
Chung, Stacey, Yanli Jin, Bingchen Han, et al.. (2017). Identification of EGF-NF-κB-FOXC1 signaling axis in basal-like breast cancer. Cell Communication and Signaling. 15(1). 22–22. 27 indexed citations
10.
Jin, Liting, Ying Qu, Stacey Chung, et al.. (2017). Characterization of primary human mammary epithelial cells isolated and propagated by conditional reprogrammed cell culture. Oncotarget. 9(14). 11503–11514. 34 indexed citations
11.
Qu, Ying, Bo Zhou, Wei Yang, et al.. (2016). Transcriptome and proteome characterization of surface ectoderm cells differentiated from human iPSCs. Scientific Reports. 6(1). 32007–32007. 27 indexed citations
12.
Johnson, Jeffrey, Michael Choi, Farnaz Dadmanesh, et al.. (2016). FOXC1 identifies basal-like breast cancer in a hereditary breast cancer cohort. Oncotarget. 7(46). 75729–75738. 12 indexed citations
13.
Han, Bingchen, et al.. (2016). FOXC1-induced Gli2 activation: A non-canonical pathway contributing to stemness and anti-Hedgehog resistance in basal-like breast cancer. Molecular & Cellular Oncology. 3(3). e1131668–e1131668. 7 indexed citations
14.
Jensen, Tor, Tania Ray, Jinhua Wang, et al.. (2015). Diagnosis of Basal-Like Breast Cancer Using a FOXC1-Based Assay. JNCI Journal of the National Cancer Institute. 107(8). 46 indexed citations
15.
Qu, Ying, Bingchen Han, Yi Yu, et al.. (2015). Evaluation of MCF10A as a Reliable Model for Normal Human Mammary Epithelial Cells. PLoS ONE. 10(7). e0131285–e0131285. 197 indexed citations
16.
Jin, Yanli, Bingchen Han, Ruprecht Wiedemeyer, et al.. (2014). FOXC1 is a Critical Mediator of EGFR Function in Human Basal-like Breast Cancer. Annals of Surgical Oncology. 21(S4). 758–766. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026